
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 5 543-548, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
X Wang, DC Christiani, JK Wiencke, M Fischbein, X Xu, TJ Cheng, E Mark, JC Wain and KT Kelsey
Occupational Health Program, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
It has been proposed that the patterns of mutations in the p53 tumor suppressor gene will provide clues to the mechanisms of cancer occurrence. Cigarette smoking is known to be the greatest risk factor for lung cancer. Epidemiological evidence has also implicated radon and asbestos as exposures that significantly increase this disease risk; asbestos exposure synergistically enhances the lung cancer risk of smokers. Previous studies of the mutational spectra of the p53 gene in lung cancer have shown cigarette smoke and radon exposure to be associated with the induction of particular lesions or classes of lesions. We have investigated the p53 gene in surgically resectable lung cancers in 85 patients from the Massachusetts General Hospital. We found 25 (29%) patients to have somatic p53 mutations in their tumors. The patients with p53 mutations who were current smokers were significantly older (75.1 versus 59.8 years; P < 0.01 and had smoked for significantly more years (56.8 versus 41.2 years; P < 0.01) than had those without p53 changes. Consistent with other reports, we observed a large number (40%) of G:C to T:A transversion mutations, noting that their occurrence increased with increasing cumulative exposure to cigarette smoke. Interestingly, we also found that p53 mutations occurred significantly more frequently in patients with a history of occupational exposure to asbestos [3 of 60 (5%) for patients without p53 mutations versus 5 of 25 (20%) of those with p53 mutations; P < 0.05].(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
K. S. Kraunz, M. D. McClean, H. H. Nelson, E. Peters, H. Calderon, and K. T. Kelsey Duration but not Intensity of Alcohol and Tobacco Exposure Predicts p16INK4A Homozygous Deletion in Head and Neck Squamous Cell Carcinoma. Cancer Res., April 15, 2006; 66(8): 4512 - 4515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Furberg, R. C. Millikan, J. Geradts, M. D. Gammon, L. G. Dressler, C. B. Ambrosone, and B. Newman Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Miller, G. Liu, I. De Vivo, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani Combinations of the Variant Genotypes of GSTP1, GSTM1, and p53 Are Associated with an Increased Lung Cancer Risk Cancer Res., May 1, 2002; 62(10): 2819 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Kim, H. H. Nelson, J. K. Wiencke, S. Zheng, D. C. Christiani, J. C. Wain, E. J. Mark, and K. T. Kelsey p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer Cancer Res., April 1, 2001; 61(8): 3419 - 3424. [Abstract] [Full Text] |
||||
![]() |
S. A. Ahrendt, J. T. Chow, S. C. Yang, L. Wu, M.-J. Zhang, J. Jen, and D. Sidransky Alcohol Consumption and Cigarette Smoking Increase the Frequency of p53 Mutations in Non-Small Cell Lung Cancer Cancer Res., June 1, 2000; 60(12): 3155 - 3159. [Abstract] [Full Text] |
||||
![]() |
H. H. Nelson, D. C. Christiani, J. K. Wiencke, E. J. Mark, J. C. Wain, and K. T. Kelsey k-ras Mutation and Occupational Asbestos Exposure in Lung Adenocarcinoma: Asbestos-related Cancer without Asbestosis Cancer Res., September 1, 1999; 59(18): 4570 - 4573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text] |
||||
![]() |
A. Yngveson, C. Williams, A. Hjerpe, J. Lundeberg, P. Söderkvist, and G. Pershagen p53 Mutations in Lung Cancer Associated with Residential Radon Exposure Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 433 - 438. [Abstract] [Full Text] |
||||
![]() |
K. Husgafvel-Pursiainen, A. Karjalainen, A. Kannio, S. Anttila, T. Partanen, A. Ojajärvi, and H. Vainio Lung Cancer and Past Occupational Exposure to Asbestos . Role of p53 and K-ras Mutations Am. J. Respir. Cell Mol. Biol., April 1, 1999; 20(4): 667 - 674. [Abstract] [Full Text] |
||||
![]() |
M. D. Gammon, H. Hibshoosh, M. B. Terry, S. Bose, J. B. Schoenberg, L. A. Brinton, J. L. Bernstein, and W. D. Thompson Cigarette Smoking and Other Risk Factors in Relation to p53 Expression in Breast Cancer among Young Women Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 255 - 263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |